Drawing for PEDESTAL

USPTO serial 99705345

PEDESTAL

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
SNABB, SANDRA MARIE
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with PEDESTAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Amy Wright

Amy Wright Taft Stettinius & Hollister LLPOne Indiana Square, Suite 3500Indianapolis, IN 46402United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for clinical research, healthcare analytics, and pharmaceutical development; Downloadable computer software for clinical research data management, healthcare data analytics, pharmaceutical research; Downloadable computer software using artificial intelligence (AI) for analyzing medical and life sciences dataACTIVE—
035Data processing services in the field of clinical research, healthcare analytics, and pharmaceutical development; Data processing services in the field of medical research; Data processing services; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugsACTIVE—
042Providing temporary use of non-downloadable cloud-based software for clinical research, healthcare analytics, and pharmaceutical development; Software as a service (SAAS) services featuring software for clinical research, healthcare analytics, and pharmaceutical development; Software as a service (SAAS) services featuring software for real-world data (RWD) analysis and real-world evidence (RWE) generation; Platform as a service (PAAS) featuring computer software platforms for clinical research, healthcare analytics, and pharmaceutical development; Platform as a service (PAAS) featuring computer software platforms for clinical trial design and optimization; Providing temporary use of non-downloadable cloud-based software for clinical research data aggregation, harmonization, management, analytics, and visualization; Design and development of computer software for pharmaceutical research and healthcare analytics; Application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software and web sites of others in the fields of clinical research collaboration; Hosting an on-line community web site featuring clinical research collaboration; Computer services, namely, hosting and maintaining an on-line web site for others for clinical research collaboration; Computer services, namely, hosting an interactive web site that allows clinical research collaboration; Hosting on-line web facilities for others for clinical research collaboration; Scientific research and development; Computer programming services for data processing; Software engineering services for data processing; Consulting services for others in the field of design, planning, and implementation project management of clinical trials for others; Scientific research in the nature of conducting clinical trials for others; Medical and scientific research in the field of pharmaceuticals; Compiling data for research purposes in the field of medical science and medical consultancy; Providing information about medical research in the field of drug development; Medical research servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (NOAM): A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.

DateCodeEventWhat it means
Sep 15, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 21, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 21, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 15, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2026DOCKASSIGNED TO EXAMINER—
Mar 16, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 16, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance